About This Calculator

The Pembrolizumab (Keytruda) Dosing Schedule Calculator is an informational resource designed for healthcare professionals. It helps visualize and map out potential treatment schedules based on the two approved flat-dose regimens for adult patients. This tool is not a substitute for clinical judgment or official prescribing information.

Outputs

After entering the required parameters, the calculator generates a clear, tabular schedule. The output table includes:

• Cycle Number: The sequential number for each treatment cycle.
• Dose: The planned dose for that cycle (200 mg or 400 mg).
• Scheduled Date: The calculated date for administration. Dates that have been automatically adjusted to avoid a weekend will be marked with an asterisk (*).

How to Use

To generate a dosing schedule, follow these steps:

1. Enter Treatment Start Date: Select the first day of the first cycle. This date cannot be in the past.
2. Select Dosing Regimen: Choose either the 200 mg every 3 weeks (Q3W) or the 400 mg every 6 weeks (Q6W) option.
3. Set Number of Cycles: Input the desired number of treatment cycles to plan (e.g., 1 to 52).
4. Choose Weekend Adjustment: Optionally, select a rule to automatically move appointments that fall on a Saturday or Sunday to the preceding Friday or the following Monday.
5. Generate Schedule: Click the "Generate Schedule" button to view the results.

Dosing Overview

Pembrolizumab (Keytruda) is administered as an intravenous infusion over 30 minutes. For adults, there are two approved flat-dosing regimens:

• 200 mg every 3 weeks (Q3W)
• 400 mg every 6 weeks (Q6W)

The choice of regimen depends on the indication, institutional protocols, and clinical judgment. This calculator does not cover pediatric dosing, which is weight-based (2 mg/kg, up to a maximum of 200 mg, every 3 weeks).

Switching Regimens

According to the prescribing information, patients may be switched between the 3-week and 6-week schedules. When switching:

• From 200 mg Q3W to 400 mg Q6W: Administer the first 400 mg dose three weeks after the last 200 mg dose.
• From 400 mg Q6W to 200 mg Q3W: Administer the first 200 mg dose six weeks after the last 400 mg dose.

Missed Dose

If a planned dose of pembrolizumab is missed, it should be administered as soon as reasonably possible. The treatment schedule should then be adjusted to maintain the correct interval (3 or 6 weeks) between doses from the new administration date. Do not administer two doses to compensate for a missed one.

Safety Alerts

This tool generates an ideal, uninterrupted schedule. In clinical practice, treatment may be delayed, interrupted, or discontinued due to adverse reactions, such as immune-mediated pneumonitis, colitis, hepatitis, and endocrinopathies. All treatment decisions must be based on a complete clinical assessment of the patient. Always consult the full Prescribing Information for detailed safety data, warnings, and precautions.

Frequently Asked Questions

Can this calculator be used for pediatric patients?

No. This tool is designed only for the approved adult flat-dose regimens (200 mg Q3W and 400 mg Q6W) and does not calculate the weight-based pediatric dose.

What does the asterisk (*) next to a date in the schedule mean?

An asterisk indicates that the originally calculated date fell on a weekend (Saturday or Sunday) and has been automatically moved to the nearest weekday based on your selected preference (previous Friday or next Monday).

Does the calculator account for treatment delays due to toxicity?

No. The calculator generates a projected schedule assuming all doses are administered on time. Any real-world delays due to toxicity or other clinical reasons will require a manual recalculation or adjustment of the schedule by the healthcare provider.

How many cycles of Keytruda are typically given?

The duration of treatment with pembrolizumab varies by cancer type and stage. It is often continued until disease progression or unacceptable toxicity, with treatment duration sometimes lasting up to 24 months in certain settings.

Can I start the calculator with a date in the past?

No. The "Treatment Start Date" field is restricted to the current date or any future date to ensure it is used for planning prospective treatment courses.

What is the maximum number of cycles I can calculate?

The tool allows you to generate a schedule for up to 52 cycles, which covers multiple years of potential treatment planning.

Is the 400 mg Q6W regimen approved for all adult indications?

Yes, the 400 mg every 6 weeks dosing option is an approved regimen for all adult indications of Keytruda, providing a less frequent dosing alternative.

How is Pembrolizumab administered?

Pembrolizumab is administered as an intravenous (IV) infusion over a period of 30 minutes. It should not be administered as an IV push or bolus injection.

References